Genetics
Genetic Modulation of Lipid-Associated Disability Progression in Multiple Sclerosis21, Jul 2026
21, Jul 2026
20, Jul 2026
18, Jul 2026
17, Jul 2026
Alper Bülbül
21, Jul 2026
This blog post examines evidence that lipid metabolism and inherited genetic variation may jointly influence disability progression in multiple sclerosis. Drawing on a five-year longitudinal cohort study, it explains how a cumulative score based on lipid-related genetic polymorphisms was associated with faster annualised EDSS progression and modified the effects of HDL cholesterol and the total cholesterol-to-HDL ratio. The article also evaluates the study’s biological implications, methodological limitations and potential relevance to biomarker development, patient stratification and future precision-medicine approaches in multiple sclerosis.
Read more20, Jul 2026
18, Jul 2026
17, Jul 2026
